Benchmark against your competition
Understand how AI crawlers access your site
See where AI gets info about you
Track the queries mentioning your brand
Own your AI narrative
Add GEO to your service offerings
Get recommended in shopping queries
Monitor AI mentions at scale
Aprecia Pharmaceuticals specializes in innovative 3D printing technologies for pharmaceutical manufacturing, focusing on oral drug delivery through unique formulations. With over 20 years of experience and a strong patent portfolio, Aprecia aims to revolutionize drug delivery and enhance the efficiency of pharmaceutical production.
Claim this profile to keep your information accurate and add what's missing.
Aprecia offers advanced 3D printing technologies that enable the development of novel oral drug delivery forms and precision formulations.
Collaborative services for novel formulations and 3D printing manufacturing to reduce risk and accelerate product development.
cGMP compliant manufacturing services for clinical trial supplies and commercial-scale production.
Aprecia Pharmaceuticals is known for being the first company to secure regulatory approval for 3D-printed pharmaceuticals, specializing in advanced additive manufacturing.
Aprecia offers development services for novel formulations, manufacturing services for clinical and commercial production, and advanced 3D printing technology.
The specific headquarters location is not mentioned, but Aprecia operates a cGMP compliant manufacturing facility.
Aprecia serves the pharmaceutical industry, focusing on drug delivery and manufacturing solutions.
Spritam is the first and only 3D-printed pharmaceutical product, validating Aprecia's capabilities in utilizing 3D printing for high-dose orodispersible formulations.